Bit surprised since I believe folks generally have a good opinion of John Carroll's accuracy. Endpoints trying to rush to publish first with their new platform? Anyway, your careful analysis is why you are "Dew"Diligence.
That aside, BMY has moved nicely the past seven days regardless of overall drug companies' performance. Technically almost every indicator positive and lots of room until it is overbought.
News 
Market Data 
Discover 
